Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Am J Pathol. 2010 Aug;177(2):896-907. doi: 10.2353/ajpath.2010.091280. Epub 2010 Jul 1.
We have previously isolated GRIM-19, a novel growth suppressor, using a genetic method. GRIM-19 ablates cell growth by inhibiting the transcription factor signal transducer and activator of transcription 3 (STAT3). Up-regulation of STAT3 and growth promotion were observed in a number of human tumors. Although the tumor-suppressive actions of GRIM-19 are known, the structural elements required for its antitumor actions are not understood. Mutational and protein sequence analyses identified a motif in the N terminus of GRIM-19 that exhibited similarity to certain RNA viral proteins. We show that disruption of specific amino acids within this motif cripples the antitumor actions of GRIM-19. These mutants fail to interact with STAT3 efficiently and consequently do not inhibit growth-promoting gene expression. More importantly, we show that a clinically observed mutation in the N terminus of GRIM-19 also weakened its interaction with STAT3 and antitumor action. Together, these studies identify a major role for the N terminus of GRIM-19 in mediating its tumor-suppressive actions.
我们先前使用一种遗传方法分离出了一种新的生长抑制剂 GRIM-19。GRIM-19 通过抑制转录因子信号转导和转录激活因子 3(STAT3)来抑制细胞生长。在许多人类肿瘤中观察到 STAT3 的上调和生长促进。尽管已知 GRIM-19 具有肿瘤抑制作用,但尚不清楚其抗肿瘤作用所需的结构元件。突变和蛋白质序列分析在 GRIM-19 的 N 端鉴定出一个与某些 RNA 病毒蛋白具有相似性的基序。我们表明,破坏该基序内的特定氨基酸会削弱 GRIM-19 的抗肿瘤作用。这些突变体不能有效地与 STAT3 相互作用,因此不能抑制促进生长的基因表达。更重要的是,我们表明 GRIM-19 N 端的临床观察到的突变也削弱了它与 STAT3 的相互作用和抗肿瘤作用。总之,这些研究确定了 GRIM-19 的 N 端在介导其肿瘤抑制作用中的主要作用。